UOC Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan (Italy).
UOC Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan (Italy);
Epidemiol Prev. 2021;45(6):477-485. doi: 10.19191/EP21.6.115.
since the beginning of the COVID-19 pandemic, specific characteristics of the infected subjects appeared to be associated with a severe disease, leading to hospitalization or death.
to evaluate the association between three components of the metabolic syndrome (diabetes mellitus, dyslipidaemia, and hypertension), alone and in combination, and risk of hospitalization in subjects with nasopharyngeal swab-confirmed COVID-19.
cohort study.
the study subjects were all COVID-19 cases diagnosed in the area of the Agency for Health Protection of the Metropolitan Area of Milan (Lombardy Region, Northern Italy) between 10.02.2020 and 25.04.2020, whose data were gathered with an ad hoc information system developed at the beginning of the pandemic.
the association between metabolic syndrome components (alone and in combination) and hospitalization (both in any ward and in intensive care unit) was measured by means of cause-specific Cox models with gender, age, and comorbidities as potential confounders.
the cohort included 15,162 subjects followed from diagnosis up to 20.07.2020. Adjusted hazard ratios (HRs) of hospitalization in any ward estimated by the Cox model were 1.26 for uncomplicated diabetes mellitus (95%CI 1.18-1.34); 1.21 for complicated diabetes mellitus (95%CI 1.05-1.39); 1.07 for dyslipidaemia (95%CI 1.00-1.14); and 1.11 for hypertension (95%CI 1.05-1.17). When all components coexisted in the same subject, the HR was 1.46 (95%CI 1.31-1.62). A significant increase in risk of hospitalization in intensive care unit was found for uncomplicated diabetes mellitus (HR 1.38; 95%CI 1.15-1.66).
this population-based study confirms that metabolic syndrome components increase the risk of hospitalization for COVID-19. The HR increases in an additive manner when the three components are simultaneously present.
自 COVID-19 大流行开始以来,感染患者的特定特征似乎与严重疾病有关,导致住院或死亡。
评估代谢综合征(糖尿病、血脂异常和高血压)的三个组成部分单独和联合与经鼻咽拭子确诊 COVID-19 患者住院风险之间的关系。
队列研究。
研究对象均为 2020 年 2 月 10 日至 4 月 25 日期间在米兰大都市区卫生局(意大利北部伦巴第大区)确诊的 COVID-19 病例,其数据通过大流行初期开发的专门信息系统收集。
以性别、年龄和合并症为潜在混杂因素,采用特定于原因的 Cox 模型衡量代谢综合征组成部分(单独和联合)与住院(普通病房和重症监护病房)之间的关系。
队列纳入了 15162 名从确诊起至 2020 年 7 月 20 日进行随访的患者。Cox 模型估计的普通病房住院调整危险比(HR)分别为:单纯性糖尿病 1.26(95%CI 1.18-1.34);复杂性糖尿病 1.21(95%CI 1.05-1.39);血脂异常 1.07(95%CI 1.00-1.14);高血压 1.11(95%CI 1.05-1.17)。当同一患者同时存在所有成分时,HR 为 1.46(95%CI 1.31-1.62)。单纯性糖尿病患者发生重症监护病房住院的风险显著增加(HR 1.38;95%CI 1.15-1.66)。
这项基于人群的研究证实,代谢综合征成分会增加 COVID-19 住院的风险。当三个成分同时存在时,HR 呈累加方式增加。